OSIR Share Price

Open 5.14 Change Price %
High 5.44 1 Day 0.26 5.06
Low 4.97 1 Week -0.28 -4.93
Close 5.40 1 Month -1.24 -18.67
Volume 191370 1 Year -4.71 -46.59
52 Week High 10.98
52 Week Low 3.55
OSIR Important Levels
Resistance 2 5.84
Resistance 1 5.66
Pivot 5.27
Support 1 5.14
Support 2 4.96
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ETRM 0.07 0.00%
AAPL 113.86 1.55%
AAPL 113.86 1.55%
More..
NASDAQ USA Top Gainers Stocks
HTCO 11.00 62.96%
LOCM 0.09 50.00%
OPXA 1.21 40.70%
QKLS 0.18 38.46%
ZAZA 0.08 33.33%
MOSY 0.46 31.43%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PPHM 0.40 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
BGMD 0.05 -37.50%
More..

Osiris Therapeutics, Inc. (NASDAQ: OSIR)

OSIR Technical Analysis 1.5
As on 9th Dec 2016 OSIR Share Price closed @ 5.40 and we RECOMMEND Sell for LONG-TERM with Stoploss of 5.60 & Buy for SHORT-TERM with Stoploss of 5.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
OSIR Target for December
1st Target up-side 7.8
2nd Target up-side 9.09
3rd Target up-side 10.39
1st Target down-side 4.1
2nd Target down-side 2.81
3rd Target down-side 1.51
OSIR Other Details
Segment EQ
Market Capital 341827424.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.osiristx.com
OSIR Address
OSIR
7015 Albert Einstein Drive
Columbia, MD 21046
United States
Phone: 443-545-1800
Fax: 443-545-1701
Interactive Technical Analysis Chart Osiris Therapeutics, Inc. ( OSIR NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Osiris Therapeutics, Inc.
OSIR Business Profile
Osiris Therapeutics, Inc. (Osiris), is a stem cell therapeutic company. The Company focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The Company operates in two business segments: Therapeutics and Biosurgery. The Company's Therapeutics business is focused on developing biologic stem cell drug candidates from a readily available and non-controversial source, adult bone marrow. The Company's Biosurgery business, works to harness the ability of cells and novel constructs to promote the body's natural healing. In the Company's Biosurgery business, the Company manufactures , market and distributes Grafix and Ovation for tissue repair. In the Company's Therapeutics segment, its pipeline of internally developed biologic drug candidates under evaluation includes Prochymal for inflammatory, autoimmune and cardiovascular indications, as well as Chondrogen for arthritis in the knee.